Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

Recent & Breaking News (CSE:BNXT)

XPhyto Provides Updated Comments on Promotional and Marketing Activity

Accesswire February 26, 2021

XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests

Accesswire February 24, 2021

XPhyto Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Test

Accesswire February 22, 2021

XPhyto Reports Vektor Pharma GMBH Lawsuit

Accesswire February 19, 2021

XPhyto European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test

Accesswire February 16, 2021

XPhyto Adds Mescaline Production to Psychedelic Medicine Programs

Accesswire February 10, 2021

XPhyto Announces Psychedelic Pharmaceutical Production Agreement

Accesswire February 3, 2021

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

Accesswire January 28, 2021

XPhyto Provides Comments on Promotional and Marketing Activity

Accesswire January 22, 2021

XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact

Accesswire January 18, 2021

XPhyto Therapeutics Closes Fully Subscribed Private Placement

Accesswire January 15, 2021

XPhyto Therapeutics Announces Private Placement

Accesswire January 5, 2021

XPhyto Completes Successful SARS-CoV-2 RT-PCR Diagnostic Test Kit Validation

Accesswire December 17, 2020

Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020

GlobeNewswire December 14, 2020

XPhyto to Present at LD Micro Main Event

Accesswire December 11, 2020

XPhyto Therapeutics Closes Investment

Accesswire December 8, 2020

XPhyto to Webcast Live at Life Sciences Investor Forum December 17th

GlobeNewswire December 8, 2020

RE-TRANSMISSION: XPhyto Secures Exclusive Psychedelic Drug Development Agreement

Accesswire November 10, 2020

XPhyto Secures Exclusive Psychedelic Drug Development Agreement

Accesswire November 10, 2020

RE-TRANSMISSION: XPhyto Appoints European Healthcare Executive to Board of Directors

Accesswire November 5, 2020